Coronavirus HIGHLIGHTS: AstraZeneca, Pfizer Vaccines Effective Against Delta Covid-19 Variants, Says Report
Coronavirus HIGHLIGHTS, Wednesday 23 June: The Delta Plus mutation of Covid-19 has posed another threat for the Country. Witnessing rising cases of Delta variant, the Union Health Ministry has declared it as 'variant of concern' in India. 22 cases of Delta Plus variant have been found, 16 of them being reported from Maharashtra and the remaining from Madhya Pradesh and Kerala. The three states have been put on alert. Meanwhile, Bharat Biotech’s Covaxin vaccine has shown the efficacy of 77.8 per cent from the trial conducted on 25,800 subjects across the country. US-based Pfizer on the other hand, is in its final stages to get approval for its Covid-19 vaccine in India.
LIVE
Background
Coronavirus HIGHLIGHTS, Wednesday 23 June: While the number of daily Covid cases has remained under 50,000 in past few days, the Delta Plus mutation Covid-19 has posed another threat for the Country. Witnessing rising cases of Delta Plus variant, the Union Health Ministry has declared it as 'variant of concern' in India. 22 cases of Delta Plus variant have been found, 16 of them being reported from Maharashtra and the remaining from Madhya Pradesh and Kerala. Maharashtra, Kerala and madhya Pradesh have been put on alert.
Meanwhile, Bharat Biotech’s Covaxin vaccine has shown the efficacy of 77.8 per cent from the trial conducted on 25,800 subjects across the country. US-based Pfizer on the other hand, is in its final stages to get approval for its Covid-19 vaccine in India.
Relaxation In Chandigarh Night Curfew Timings
42 Cases of Delta Plus Variant In India
We have around 42 cases of Delta Plus variant in India, so it is difficult to say whether it is causing anything on which we should be worried about, says AIIMS Director Dr. Randeep Guleria.
One Case Of Delta Variant In Jammu
One Case of Delta variant has been confirmed in Jammu and the patient has recovered: Government Medical College and Hospital
Pfizer Close To Reaching Agreement: AIIMS Director
Pfizer is negotiating as far as the various clauses are concerned and they are close to reaching an agreement with the government. AIIMS Director Dr. Randeep Guleria informed that once that process is done it will shortly be able to have Pfizer's covid vaccine in India.
First Case Of Covid's Delta+ Strain Reported In Mysuru
Karnataka Health Minister K. Sudhakar on Wednesday said that the first case of Delta Plus strain of Covid-19 has been reported in Mysuru and the infected person is asymptomatic.
"In Mysuru, one patient is infected with Delta Plus variant, whom we have isolated but he is asymptomatic and none of his primary and secondary contacts have it which is a good sign," Sudhakar said.
Trending News
Top Headlines
